Hidden threats: Brucellosis diagnosis and co-infection patterns in Crimean-Congo Hemorrhagic Fever suspects

dc.authoridcubuk, fatih/0000-0002-8976-7691
dc.authoridBUYUKTUNA, SEYIT ALI/0000-0001-6518-7361
dc.authoridhasbek, mursit/0000-0002-5217-8607
dc.authoridOz, Murtaza/0000-0003-3415-5927
dc.contributor.authorOz, Murtaza
dc.contributor.authorCubuk, Fatih
dc.contributor.authorKiymaz, Yasemin cakir
dc.contributor.authorOksuz, Caner
dc.contributor.authorHasbek, Mursit
dc.contributor.authorBuyuktuna, Seyit Ali
dc.contributor.authorElaldi, Nazif
dc.date.accessioned2025-05-04T16:47:13Z
dc.date.available2025-05-04T16:47:13Z
dc.date.issued2025
dc.departmentSivas Cumhuriyet Üniversitesi
dc.description.abstractPurpose: This study aims to investigate the frequency of brucellosis in patients with Crimean-Congo Hemorrhagic Fever (CCHF). Method: In this study, 1231 patients were evaluated retrospectively, including 14 patients with CCHF and brucellosis coinfection and 25 patients with brucellosis alone. Statistical methods such as the Mann-Whitney U test and Fisher's exact test were used. Result: Of the patients with a preliminary diagnosis of Crimean-Congo Hemorrhagic Fever (CCHF), 3.2% were found to have brucellosis. In the group co-infected with brucellosis and CCHF, the time to hospital admission was shorter. Additionally, tick exposure and headache were observed more frequently in this group. Creatine kinase levels were found to be higher in the co-infected group, while lymphocyte counts and fibrinogen levels were lower compared to the group with brucellosis alone. Conclusion: Our study revealed a 3.2% rate of brucellosis in patients with a preliminary diagnosis of CCHF. Due to the similarity of symptoms and common risk factors, the differential diagnosis of brucellosis should be considered in patients diagnosed with CCHF. Additionally, the possibility of brucellosis coexisting with CCHF should always be considered. Even in patients diagnosed with CCHF, an evaluation for brucellosis must be conducted.
dc.identifier.doi10.1016/j.diagmicrobio.2025.116724
dc.identifier.issn0732-8893
dc.identifier.issn1879-0070
dc.identifier.issue3
dc.identifier.pmid39904148
dc.identifier.scopus2-s2.0-85216617817
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1016/j.diagmicrobio.2025.116724
dc.identifier.urihttps://hdl.handle.net/20.500.12418/35535
dc.identifier.volume111
dc.identifier.wosWOS:001422383900001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Science Inc
dc.relation.ispartofDiagnostic Microbiology and Infectious Disease
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250504
dc.subjectBrucella Infections
dc.subjectCrimean-Congo Hemorrhagic Fever Virus
dc.subjectCo-infection
dc.titleHidden threats: Brucellosis diagnosis and co-infection patterns in Crimean-Congo Hemorrhagic Fever suspects
dc.typeArticle

Dosyalar